150 related articles for article (PubMed ID: 31273159)
1. [Patient-Reported Outcome(PRO)to Measure Health-Related QOL in Lung Cancer Patients].
Sone S; Hase K; Takezaki A; Kakiuchi S; Konaka K
Gan To Kagaku Ryoho; 2019 Jun; 46(6):974-980. PubMed ID: 31273159
[TBL] [Abstract][Full Text] [Related]
2. Patient-reported outcome measures (PROMs) in the management of lung cancer: A systematic review.
Bouazza YB; Chiairi I; El Kharbouchi O; De Backer L; Vanhoutte G; Janssens A; Van Meerbeeck JP
Lung Cancer; 2017 Nov; 113():140-151. PubMed ID: 29110842
[TBL] [Abstract][Full Text] [Related]
3. Patient-Reported Outcome Measures Used in Routine Care Predict for Survival at Disease Progression in Patients With Advanced Lung Cancer.
Friis RB; Hjøllund NH; Pappot H; Taarnhøj GA; Vestergaard JM; Skuladottir H
Clin Lung Cancer; 2021 Mar; 22(2):e169-e179. PubMed ID: 33160899
[TBL] [Abstract][Full Text] [Related]
4. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life.
Bergman B; Aaronson NK; Ahmedzai S; Kaasa S; Sullivan M
Eur J Cancer; 1994; 30A(5):635-42. PubMed ID: 8080679
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in patients with lung cancer: validation of the Mexican-Spanish version and association with prognosis of the EORTC QLQ-LC13 questionnaire.
Arrieta Ó; Núñez-Valencia C; Reynoso-Erazo L; Alvarado S; Flores-Estrada D; Angulo LP; Oñate-Ocaña LF
Lung Cancer; 2012 Jul; 77(1):205-11. PubMed ID: 22387006
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
[TBL] [Abstract][Full Text] [Related]
7. Development of a hospital-based patient-reported outcome framework for lung cancer patients: a study protocol.
Moloczij N; Gough K; Solomon B; Ball D; Mileshkin L; Duffy M; Krishnasamy M
Health Qual Life Outcomes; 2018 Jan; 16(1):10. PubMed ID: 29325571
[TBL] [Abstract][Full Text] [Related]
8. Effect of Brain Metastasis on Patient-Reported Outcomes in Advanced NSCLC Treated in Real-World Community Oncology Settings.
Walker MS; Wong W; Ravelo A; Miller PJE; Schwartzberg LS
Clin Lung Cancer; 2018 Mar; 19(2):139-147. PubMed ID: 29103883
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of quality of life score in disease-free survivors of surgically-treated lung cancer.
Yun YH; Kim YA; Sim JA; Shin AS; Chang YJ; Lee J; Kim MS; Shim YM; Zo JL
BMC Cancer; 2016 Jul; 16():505. PubMed ID: 27439430
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of patient-reported outcome measures in the surgical treatment of patients with esophageal cancer.
Straatman J; Joosten PJ; Terwee CB; Cuesta MA; Jansma EP; van der Peet DL
Dis Esophagus; 2016 Oct; 29(7):760-772. PubMed ID: 26471471
[TBL] [Abstract][Full Text] [Related]
11. Exercise capacity and cancer-specific quality of life following curative intent treatment of stage I-IIIA lung cancer.
Ha D; Ries AL; Mazzone PJ; Lippman SM; Fuster MM
Support Care Cancer; 2018 Jul; 26(7):2459-2469. PubMed ID: 29429006
[TBL] [Abstract][Full Text] [Related]
12. Comparison of instruments for measuring quality of life in patients with lung cancer.
Hollen PJ; Gralla RJ
Semin Oncol; 1996 Apr; 23(2 Suppl 5):31-40. PubMed ID: 8610235
[TBL] [Abstract][Full Text] [Related]
13. Patient-reported outcomes (PROs) in lung cancer: Experiences from a nationwide feasibility study.
Brønserud MM; Iachina M; Green A; Groenvold M; Dørflinger L; Jakobsen E
Lung Cancer; 2019 Feb; 128():67-73. PubMed ID: 30642456
[TBL] [Abstract][Full Text] [Related]
14. Cross-Sectional Patient-Reported Outcome Measuring of Health-Related Quality of Life With Establishment of Cancer- and Treatment-Specific Functional and Symptom Scales in Patients With Penile Cancer.
Draeger DL; Sievert KD; Hakenberg OW
Clin Genitourin Cancer; 2018 Dec; 16(6):e1215-e1220. PubMed ID: 30201215
[TBL] [Abstract][Full Text] [Related]
15. Quality of life in patients with lung cancer: a review of literature from 1970 to 1995.
Montazeri A; Gillis CR; McEwen J
Chest; 1998 Feb; 113(2):467-81. PubMed ID: 9498968
[TBL] [Abstract][Full Text] [Related]
16. Cancer patients' understanding of longitudinal EORTC QLQ-C30 scores presented as bar charts.
Loth FL; Holzner B; Sztankay M; Bliem HR; Raoufi S; Rumpold G; Giesinger JM
Patient Educ Couns; 2016 Dec; 99(12):2012-2017. PubMed ID: 27506581
[TBL] [Abstract][Full Text] [Related]
17. A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol.
Efficace F; Boccadoro M; Palumbo A; Petrucci MT; Cottone F; Cannella L; Zamagni E; Niscola P; Kyriakou C; Caravita T; Offidani M; Mandelli F; Cavo M
Health Qual Life Outcomes; 2018 Jun; 16(1):127. PubMed ID: 29914509
[TBL] [Abstract][Full Text] [Related]
18. A randomised assessment of the use of a quality of life questionnaire with or without intervention in patients attending a thoracic cancer clinic.
Nimako K; Ayite B; Priest K; Severn J; Fries HM; Gunapala R; Bhosle J; Popat S; O'Brien M
Eur J Cancer Care (Engl); 2017 Jul; 26(4):. PubMed ID: 26556778
[TBL] [Abstract][Full Text] [Related]
19. First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.
Gebbia V; Lorusso V; Galetta D; Caruso M M; Palomba G; Riccardi F; Borsellino N; Carrozza F; Leo S; Ferraù F; Cinieri S; Mancuso G; Mancarella S; Colucci G
Lung Cancer; 2010 Aug; 69(2):218-24. PubMed ID: 19910076
[TBL] [Abstract][Full Text] [Related]
20. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.
Wallwiener M; Matthies L; Simoes E; Keilmann L; Hartkopf AD; Sokolov AN; Walter CB; Sickenberger N; Wallwiener S; Feisst M; Gass P; Fasching PA; Lux MP; Wallwiener D; Taran FA; Rom J; Schneeweiss A; Graf J; Brucker SY
J Med Internet Res; 2017 Sep; 19(9):e322. PubMed ID: 28912116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
